Investing.com - Merck reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Merck announced earnings per share of €2.41 on revenue of €5.2B. Analysts polled by Investing.com anticipated EPS of €2.34 on revenue of €5.06B.
Merck shares are down 10% from the beginning of the year, still down 31.27% from its 52 week high of €231.50 set on December 30, 2021. They are under-performing the IBEX 35 which is down 6.29% from the start of the year.
Merck shares lost 6.16% in intra-day trade following the report.
Merck follows other major Healthcare sector earnings this month
Merck's report follows an earnings beat by Bayer on Tuesday, who reported EPS of €3.53 on revenue of €14.64B, compared to forecasts EPS of €2.96 on revenue of €13.82B.
Siemens Healthineers had beat expectations on May 4 with second quarter EPS of €0.67 on revenue of €5.46B, compared to forecast for EPS of €0.5486 on revenue of €5.02B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar